Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
Details
Publication Year 2022-07,Volume 82,Issue #1,Page 146-147
Journal Title
European Urology
Publication Type
Commentary
Keywords
Androgen Receptor Antagonists; Hormones; Humans; Male; *Prostatic Neoplasms/drug therapy; *Prostatic Neoplasms, Castration-Resistant/pathology; Pyrazoles
Department(s)
Surgical Oncology; Medical Oncology
PubMed ID
35346516
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-10-16 03:58:18
Last Modified: 2024-10-16 03:59:23
An error has occurred. This application may no longer respond until reloaded. Reload 🗙